Breaking News

ProtaGene Appoints Dr. Raymond Kaiser as CEO

Kaiser will drive the continued innovation and growth strategy for the company’s advanced analytical services.

Author Image

By: Charlie Sternberg

Associate Editor

ProtaGene GmbH, a global contract research organization focused on advanced analytics in biologics and cell and gene therapy, has appointed Raymond Kaiser, Ph.D., as chief executive officer. Kaiser will drive the continued innovation and growth strategy for the company’s advanced analytical services. Experience Kaiser first joined ProtaGene earlier this year as chief operating officer. He brings over 26 years of experience in the biopharmaceutical and CRO industries, including research and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters